Le Lézard
Classified in: Health

Home Dialysis Market - Growth Drivers, Future Trends and Forecast Analysis to 2021


PUNE, India, Nov. 10, 2017 /PRNewswire-iReach/ -- The report titled "The US Home Dialysis Market: Size, Trends & Forecasts (2017-2021)" highlights an in-depth analysis of market sizing and growth of the US Home Dialysis Market. The analysis includes market size in terms of value as well as volume and market share by segments.

Complete report on Global Home Dialysis Market spread across 52 pages with providing 4 company profiles, 5 tables and 18 figures is now available at http://www.marketreportsonline.com/687637.html.

Furthermore, the report also assesses the key opportunities available in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the US home dialysis market has also been forecasted for the period 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The competition in the US home dialysis market is stiff and majority of market share is dominated by few major players such as Fresenius Medical Care, DaVita, U.S. Renal Care and, Dialysis Clinic Inc. whose company profiling has been done in the report, which include their business overview, financial overview and respective business strategies.

The process of purifying blood by eliminating waste materials and excessive fluid from the body in case, the kidneys of the human body is not function properly is known as dialysis. In the dialysis process blood is filtered and purified with the help of technological advanced machinery. The treatment has been used since 1940s to treat patients suffering from chronic kidney diseases. It is the most widely accepted treatment for end stage renal diseases and kidney failures. The primary objective of dialysis process is to help damaged renal function. The three major types of dialysis are: Hemodialysis (HD), Peritoneal Dialysis (PD) and, Home Hemodialysis (HHD).

Purchase a copy of this "The US Home Dialysis Market: Size, Trends & Forecasts (2017-2021)" research report at USD 800 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=687637.

A home dialysis is either hemodialysis or peritoneal dialysis which can perform at home with the help of advanced machinery. A skilled clinical person can teach a person how to perform dialysis at home. Home dialysis has been recognized by patients and physicians as a safe and effective alternative to in-center treatment. Home dialysis is broadly classified into four categories: Daily home Hemodialysis (HD), Nocturnal Home hemodialysis, Nocturnal In-Center hemodialysis, Standard Home hemodialysis.

The US Home Dialysis market, both in terms of value as well as volume has increased over the past few years and projections are made that the market would grow further at a rapid pace in the forecasted period i.e. 2017-2021 also. The US home dialysis market is expected to grow on the back of aging US population, growing kidney chronic diseases, rising life expectancy of dialysis patients, convenience over in-traditional dialysis centers, technological advancements such as trend toward using sorbent technology to allow online regeneration for dialysate to facilitate portability, etc. Yet the growth of the market is obstructed by factors such as technical issues, lack of substantial housing and legal and financial requirements.

Major Points from Table of Contents:

1. Executive Summary

2. Introduction
2.1 Overview of Dialysis
2.1.1 Types of Dialysis
2.2 Overview of Home Dialysis
2.2.1 Types of Home Dialysis
2.2.2 Home Treatments Comparison: Positives and Negatives

3. The US Market Analysis
3.1 The US Dialysis Market Analysis
3.1.1 The US Dialysis Market by Volume
3.1.2 The US Dialysis Market by Segments
3.2 The US Home Dialysis Market Analysis
3.2.1 The US Home Dialysis Market by Volume
3.2.2 The US Home Dialysis Market by Value

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Aging Population
4.1.2 Growing Chronic Kidney Disease
4.1.3 Rising Life Expectancy of Dialysis Patient
4.1.4 Great Deal of Convenience over Traditional In-Center
4.1.5 Rising Healthcare Expenditure
4.2 Challenges
4.2.1 Technical Issues
4.2.2 Lack of Suitable Housing
4.2.3 Legal and Financial Requirements
4.3 Market Trends
4.3.1 Technological Advancements
4.3.2 Prospective Payment System

5. Competitive Landscape
5.1 The US Home Dialysis Market Players Comparison by Products
5.2 The US Home Dialysis Market Players by Number of Patients

6. Company Profiling

Browse all latest healthcare market research reports at www.marketreportsonline.com/cat/healthcare-market-research.html.

About Us:
Market Reports Online is a comprehensive online library of more than 100,000 reports, in-depth market research studies on thousands of micro markets and a range of industries. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe. We offer online and offline support services to ensure your research requirements are met on time. 

Media Contact: Hrishikesh Patwardhan, MarketReportsOnline, + 1 888 391 5441, [email protected]

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 

SOURCE MarketReportsOnline


These press releases may also interest you

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...



News published on and distributed by: